000 01369 a2200373 4500
005 20250515143423.0
264 0 _c20081217
008 200812s 0 0 eng d
022 _a0025-729X
024 7 _a10.5694/j.1326-5377.2008.tb02124.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrini, Musa
245 0 0 _aHepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
_h[electronic resource]
260 _bThe Medical journal of Australia
_cOct 2008
300 _a464-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aFatal Outcome
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadverse effects
650 0 4 _aInfliximab
650 0 4 _aLiver Neoplasms
_xchemically induced
650 0 4 _aLymphoma, T-Cell
_xchemically induced
650 0 4 _aMale
650 0 4 _aSplenic Neoplasms
_xchemically induced
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aPrichard, Peter J
700 1 _aBrown, Gregor J E
700 1 _aMacrae, Finlay A
773 0 _tThe Medical journal of Australia
_gvol. 189
_gno. 8
_gp. 464-5
856 4 0 _uhttps://doi.org/10.5694/j.1326-5377.2008.tb02124.x
_zAvailable from publisher's website
999 _c18391892
_d18391892